2010 annual financial data
Summit Therapeutics 2010 Operating margin
Direct answer
Operating margin was -1,270.03%.
Operating income was -9,383,000 GBP and net income was -7,422,000 GBP.
Operating cash flow was -4,336,060 GBP.
Get free Summit Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 738,802 GBP
- Operating income
- -9,383,000 GBP
- Net income
- -7,422,000 GBP
- Operating cash flow
- -4,336,060 GBP